Studies have shown that CRMP5 is an autoimmune antibody associated with paraneoplastic neurological syndrome (PNS) and often associated with small cell lung cancer or thymoma (Brot et al., 2013; Rajesh & Bernhard, 2013). Here, DPYSL5 is linked to Autoimmunity.